Journal of Pharmacy Technology: Official Publication of the Association of Pharmacy Technicians January-December 1991: Vol 7 Index

7 Pages·2.6 MB·English

INDEX
Volume Seven — January through December 1991
the journal of Pharmacy Technology
January/February Pages 1-40 July/August Pages 121-160
March/April Pages 41-80 September/October Pages 161-212
May/June Pages 81-120 November/December Pages 213-258
A-B AIDS on Rise in Women (FL) 205 ASHP Technical Assistance Bulletin (FL) 72
Alcohol, Christians seek to ban sale in phar- Aspartame, as sweetening agent (A) 172
Acacia, as suspending agent (A) 172
macies (WN) 35; interaction with medica- Aspirin, interaction with alcohol (PF) 238; use
AccuTRAK for Improved Compliance (WN)
36 tions (PF) 238 for acute and chronic pain (A) 86
Allopurinol, adverse effects (A) 225; interac- Association Between Connective Tissue Dis-
Acetaminophen, use for acute and chronic
tion with azathioprine (A) 224 eases and Collagen (WN) 243
pain (A) 86
Altretamine, treatment of ovarian cancer Association of Pharmacy Technicians, 1991
Acne, benzoyl peroxide reclassification pro- (WN) 37 convention, 84; continuing education test,
posed (WN) 244
Alzheimer’s disease, linoprine clinical trials 40, 80, 120, 160
Activation energy, use in estimating shelf-life
(A) 177 begin (PF) 201 Atherosclerosis, garlic (PF) 71
Amifostine, chemotherapeutic protector Atrial natriuretic factor, role in syndrome of
Administering Epoetin Alfa: More RBCs
(WN) 247 inappropriate secretion of antidiuretic hor-
with Fewer Risks (FL) 156 Amitriptyline, induces syndrome of inappro- mone (A) 50
Adverse drug reactions, allopurinol (A) 225;
priate secretion of antidiuretic hormone (A) Author guidelines, JF-ifc; MA-ifc, MJ-ifc, JA-
azathioprine (A) 225; methylnaltrexone to
53 ifc, SO-ifc, ND-ifc
obviate effects of narcotics used for pain fol-
Amoh, Kwame N. (coauthor) see Timm, Auxiliary Label Use by Pharmacists in South
lowing surgery and in cancer patients
David M., 179 Carolina (A) 64
(WN) 209; proof of facts in courtrooms (NP)
Amphotericin B, generic version approved Avakian, Robert (author) Protriptyline for
4; zidovudine (WN) 210
(WN) 36 Treatment of Obstructive Sleep Apnea (A)
Advertising, FDA to examine (PF) 239; tobac- Amyotrophic lateral sclerosis, myotrophin re- 222
co (FL) 242
ceives orphan drug status (WN) 248 Azathioprine, adverse effects (A) 225; interac-
Advise About Alcohol with Every Prescrip-
Analgesics, use for acute and chronic pain (A) tion with allopurinol (A) 224
tion (PF) 238 86 Banakar, Umesh V. (coauthor) see Kirchain,
AIDS, dideoxycytidine release approved by
Anemia, epoetin alfa approved in AIDS pa- William R., 19
FDA (WN) 210; incidence increasing in
tients (WN) 36 Barbiturates, interaction with alcohol (PF) 238
women (FL) 205; not caused by human im-
Anesthesiology, satellite pharmacy (FL) 72 Barone, Eugene J. (coauthor) see Elsasser,
munodeficiency virus (PF) 29; oxandrolone
Angiotensin-converting enzyme inhibitors, Gary N., 6
classified as orphan drug (WN) 245; zi- captopril (A) 56; ramipril marketed (WN) Benazepril hydrochloride, marketing ap-
dovudine (WN) 78 79 proval received (WN) 210
AIDS Not Caused by Virus? (PF) 29
Announcements, Calgary and Area Canadian Bentonite magma, as suspending agent (A)
APT Conference 1991, 233; International 172
Conference for Pharmacy Technician Edu- Benzodiazepines, interaction with alcohol
cators, 18 (PF) 238
Antibiotics, prescribing (A) 195 Benzoic acid, as a preservative (A) 173
Anticonvulsant May Be Active in Mania (PF) Benzoyl peroxide, FDA reclassification pro-
71 posed (WN) 244
Antidepressants, interaction with alcohol (PF) Benzyl alcohol, as a preservative (A) 173
238 Beta-blockers, interaction with alcohol (PF)
Antidiuretic hormone, syndrome of inappro- 238
priate secretion (A) 51 Beta carotene, prevention of lung cancer (PF) 71
Antihistamines, interaction with alcohol (PF) Blood clotting, new agent developed (WN) 36
238 Blood pressure, monitoring (WN) 109
Antipsychotic drugs, use in long-term care fa- Book Reviews, see Publications, New
cilities (A) 13 Books Received 4, 44, 125, 166, 218
APhA Seeks Input on Code of Ethics (PF) Borcherding, Shawn M. (author) Nosocomial
154 Pneumonia in Intensive Care Patients Sec-
Arizona Pharmacy Association Examination ondary to Stress Ulcer Prophylaxis (A) 127
(PF) 201 Brain, monitor for chemical changes (PF) 29
ASHP Approves Technician Certification Brain cell, culture available for licensing (WN)
Policy (FL) 106 109
Volume 7 November/December 1991 253
Britton, Marlys E. (coauthor) see Spooner, Clark, Sherry (author) jPT: A Bargain for the Disposable, Hand-Held Cholesterol Test
Susan H., 93 Whole Department (L) 124 (WN) 247
Bromocriptine, induces syndrome of inappro- Clinical trials, liability associated with (A) 9 Divestment from Tobacco Stocks Urged
priate secretion of antidiuretic hormone (A) Clofibrate, role in syndrome of inappropriate (WN) 109
53 secretion of antidiuretic hormone (A) 51 Dombrowski, Robert C. (author) Auxiliary
Brushwood, David B. (author) book review, 4 Clonidine, induces syndrome of inappropri- Label Use by Pharmacists in South Carolina
Brydon, William L. (coauthor) see Hurley, ate secretion of antidiuretic hormone (A) 53 (A) 64
Stephen C., 59 Coagulation factor IX (human), developed Dosing errors, responsibility (E) 213; tenfold
Burlingame, Mark B. (coauthor) see Avakian, (WN) 36 (A) 219
Robert, 222 Cocaine, overview (NP) 44 Drug abuse, prevention and control (NP) 216
Burton, Michael E. (author) book review, 217 Codeine, use in pain management (A) 87 Drug costs, Canadians pay less than Ameri-
Cold-Adapted Influenza Virus Vaccine cans (WN) 34
(WN) 110 Drug formulations, oral forms, for pediatric
Collagen, association with polymyositis and patients (A) 168
dermatomyositis (WN) 243 Drug-Induced Syndrome of Inappropriate
C-E
Combination HIV Antibody Test Kits (WN) Secretion of Antidiuretic Hormone (A) 50
246 Drug information service, at King Khalid
CPhA Policies Approved (PF) 29 Community p , Christians seek to University (A) 179
Calcium, treatment and prevention of cancer limit sale of alcohol, tobacco, pornography Drupgri nien t(eAr)a c2ti2o4n s, allopurinol and azathio-
(PF) 71; treatment and prevention of hyper- in pharmacies (WN) 35
tension (PF) 71; treatment of osteoporosis Compliance, AccuTRAK label to improve Drug shelf-life, method to estimate (A) 176
(PF) 71 compliance (WN) 36; Counter Cap intro- Drug solubility, effect of compounding (A) 169
Calculations (NP) 124 duced (WN) 248; role of pharmacists (PF) Drug solutions, effect of compounding (A) 169
California, legislation to formally recognize 105; theophylline (A) 62; use of labels (A) 64 Drug stability, effect of compounding (A) 168;
technicians passes (FL) 240 Compounding, new compounder used for effect of storage temperatures (A) 176; effect
California Approves New Technician Law mixing total parenteral nutrition solutions of temperature and storage (A) 174; influ-
(PF) 201 (WN) 211; oral liquid forms (A) 173; oral ence of pH, 174
California Pharmacists Association, new medications (A) 168 Drug suspensions, effect of compounding (A)
policies (PF) 29 Computerized Medication Dispenser (WN) 170
California Technician Legislation on the 111 Drug Testing for Turner Syndrome (WN) 159
Move (PF) 104 Consulting Editors Chosen (PN) 165 Du Pont Merck Begins Alzheimer Drug Tri-
Campbell, Jefferey W. (coauthor) see Continuing education, and technicians (A) 98; als (PF) 201
Borcherding, Shawn M., 127 APT, 40, 80, 120, 160; PharmaCE, 164, 250 Editorials, Whitney, Harvey A.K. Jr., Dis-
Canadians Pay Less for Drugs Than Do Coronary artery disease, new myocardial pensing and the Technician, Part I, 1; Part
Americans (WN) 34 imaging agent (WN) 79 II, 41; Errors as a Way of Life. Part V. Who
Cancer, calcium (PF) 71; diaziquone license Cost, healthcare (FL) 241 Is Responsible?, 213; For /PT—A Problem
granted (WN) 112; lung, beta carotene (PF) Cromolyn sodium, PCCA barred from distri- Becomes an Opportunity, 121; PharmD
71; nausea and vomiting, ondansetron in- bution (WN) 35 Deja Vu! Enter the Technician, 161; The
troduced (WN) 78; ovarian, altretamine Cyclobenzaprine, interaction with alcohol Growth of jPT and Its Future, 81
(WN) 37; pain, Oramorph SR introduced (PF) 238 Education, pharmacist (E) 161; technician,
(WN) 247; photodynamic therapy patent Cyclophosphamide, induces syndrome of in- message from Arizona Pharmacy Associa-
granted (WN) 34; sargramostim marketed appropriate secretion of antidiuretic hor- tion president (FL) 203
(WN) 111; urinary bladder, tuberculosis mone (A) 52 Educators, conference (WN) 34
substrain approved (WN) 78 Cycloserine, interaction with alcohol (PF) 238 Elan Acquires Rights to Miniature Infusion
Candidiasis, vaginal, ketoconazole (A) 47 CytoGuard Safety Device (WN) 79 Pump (WN) 35
Captopril, use in diabetic proteinuria (A) 56; Dawson, Linda M. (author) Guidelines for Elderly patients, antipsychotic drugs (A) 13;
use in pediatric patients (L) 216 Compounding Oral Medications for Pedi- benazepril hydrochloride for treatment of
Captopril for Pediatric Patients (L) 216 atric Patients (A) 168 hypertension (WN) 210
Carbamazepine, causes syndrome of inappro- DDC, see dideoxycytidine Elixirs, as vehicles (A) 170
priate secretion of antidiuretic hormone (A) DDC Receives Treatment IND Status (WN) Elsasser, Gary N. (author) Phenytoin Hyper-
51 210 sensitivity Syndrome: Case Report and Dis-
Carboxymethylcellulose sodium, as suspend- de los Angeles Rodriguez, Maria (coauthor) cussion (A) 6
ing agent (A) 172 see Garcia-Ortiz, Roberto E., 224 Enhancing the Future of Pharmaceutical Ed-
Centoxin Approved in Germany and UK Demeclocycline, first-line treatment for ucation and Practice (FL) 31
(WN) 159 chronic syndrome of inappropriate secre- Enteral formulas, reduce hospital stay (PF) 29
Cephalosporins, interaction with alcohol (PF) tion of antidiuretic hormone (A) 53 Epoetin Alfa for Anemia (WN) 36
238 Depression, pyridoxine (PF) 71 Errors, medication, avoidance (NP) 165
Certification, Arizona offers examination (PF) Dermatomyositis, association with collagen Errors as a Way of Life. Part V. Who is Re-
201; examination validated (WN) 78 (WN) 243 sponsible? (E) 213
Chemotherapy, amifostine to protect tissue Dextrose, as sweetening agent (A) 171 Erskine, Linda M. (coauthor) see Spooner,
(WN) 246; ondansetron to reduce emesis Diabetes, lack of awareness (WN) 208; man- Susan H., 93
(WN) 78 agement of (A) 19; portable glucose moni- Erythropoietin, epoetin alfa approved (WN) 36
Child-resistant packaging, regulations should tor (WN) 112; proteinuria, captopril in treat- Estimating Drug Shelf Life at Various Stor-
be changed (PF) 239 ment of (A) 56 age Temperatures (A) 176
Chloral hydrate, interaction with alcohol (PF) Diabetes Overlooked in Favor of Other Life- Exclusive License Granted for Diaziquone
238 Threatening Diseases (WN) 208 (WN) 112
Chlorpropamide, induces syndrome of inap- Dideoxycytidine, FDA approves release
propriate secretion of antidiuretic hormone (WN) 210
(A) 52 Diluent for oral use, as suspending agent (A)
Cholesterol, disposable test available (WN) 247 172 F-H
Christian Pharmacists Approve Recommen- Dilutors, Repipet introduced (WN) 210
dation (WN) 35 Dispensing, computerized systems (WN) 111;
Chronic granulomatous disease, interferon pharmacists role (E) 161; state laws (E) 41; Failure of Captopril Therapy for Diabetic
gamma-1b introduced (WN) 37 technicians (E) 1, 161 Proteinuria (A) 56
Cisplatin, induces syndrome of inappropriate Dispensing and the Technician, Part I (E) 1; Fazio, Anthony (author) Failure of Captopril
secretion of antidiuretic hormone (A) 52 Part Il (E) 41 The.apy for Diabetic Proteinuria (A) 56
254 journal of Pharmacy Technology Volume 7 November/December 1991
FDA Acts on Benzoyl Peroxide (WN) 244 Historical Quotes, see Quotes, Historical Kirchain, William R. (author) Issues in Con-
FDA Reorganization (WN) 208 HIV, see human immunodefici virus temporary Drug Delivery: Part IV. Insulin
FDA Reviews New Zidovudine Data (WN) Hodge, F. Joseph (coauthor) see Hulisz, Dar- Therapy (A) 19
78 rell T., 13 Klutman, Neil E. (coauthor) see Borcherding,
FDA Watching Prescription Drug Promotion Home healthcare, technician roles (FL) 242 Shawn M., 127
(PF) 239 Hopkins Makes Brain Cell Culture Avail- Koren, Gideon (author) Use of Clinical Phar-
Fish oil, treatment and prevention of hyper- able for Licensing (WN) 109 macists to Prevent Medication Errors in
tension (PF) 71 Hulisz, Darrell T. (author) Study of Antipsy- Children (A) 219
Fisons Corporation Sues Professional Com- chotic Drug Use in Long-Term Care Facili-
pounding Centers of America (WN) 35 ties (A) 13
Flavoring agents, for pediatric patients (A) Human immunodeficiency virus, antibody
173 test kits (WN) 246
Fluphenazine, induces syndrome of inappro- Hurd, Richard H. (coauthor) see Elsasser, L-M
priate secretion of antidiuretic hormone (A) Gary N., 6
53 Hurley, Stephen C. (author) Variability of Labeling, AccuTRAK to improve compliance
Food and Drug Administration, reorganiza- Serum Theophylline Concentrations in
(WN) 36; FDA to revise sunscreen regula-
t(iAo)n 9( WN) 208; standards for clinical trials HypOeurttpeantsiieontn , Asbtenhamzaetpirci lC hhiylddrroecnh l(oAr)i d5e9 mar- Legtiisolnast i(oFnL,) d2i05s;p eanusxiinlgia r(yE )l 4a1b;e lns e(wA )l 6a4w ap-
Foundation for Innovation in Medicine (PF) keting approval received (WN) 210; calci- proved in California (PF) 201; technicians
71 um (PF) 71; fish oil (PF) 71; ramipril mar- formally recognized (FL) 240
Free Home Blood Pressure Monitors (WN) keted (WN) 79 Letters, Technician in Stuttgart Requests Infor-
109 Hypnotics, estazolam Civ marketed (WN) 79 mation, McKibben, Bruce E., 44; jPT: a Bar-
Fructose, as sweetening agent (A) 171 gain for the Whole Department, Clark,
Furosemide, interaction with alcohol (PF) 238 Sherry, Majka, Stan, 124
Gallelli, Joseph F. (author) Liability and New Liability, associated with clinical trials of in-
Drug Studies: Informed Consent and Clini- I-K vestigational new drugs (A) 9
cal Trials at the National Institutes of Liability and New Drug Studies: Informed
Health (A) 9 Consent and Clinical Trials at the Nation-
Garcia-Ortiz, Roberto E. (author) Pancytope- Immunex to Market Leukine (WN) 111 al Institutes of Health (A) 9
nia Associated with the Interaction of Al- Immunoassays, test strip screens for microal- Licensing Agreement for Methylnaltrexone
lopurinol and Azathioprine (A) 224 buminuria (WN) 211 (WN) 209
Garlic, reduction of atherosclerosis (PF) 71 Impact of a Clinical Pharmacist on Antibiotic Linoprine, clinical trials begin for treating
Genentech Granted Product License for Ac- Prescribing: A Multicenter Trial (A) 195 Alzheimer’s disease (PF) 201
timmune (WN) 37 Improving Job Satisfaction and Enlarging Lipps, Dorothyanne S., appointed jPT con-
Glipizide, does not induce syndrome of inap- the Role of Technicians (A) 93 sulting editor (JA) 165
propriate secretion of antidiuretic hormone Influenza, vaccine (WN) 110 Literature, From the, Administering Epoetin
(A) 52 Informed consent, clinical trials (A) 9; histori- Alfa: More RCBs with Fewer Risks, Nursing
Glutethimide, interaction with alcohol (PF) cal evolution (A) 10 (1991) 156; AIDS on Rise in Women, FDA
238 Infusion, insulin (A) 24; miniature pump Consumer (1991) 205; ASHP Approves
Glyburide, does not induce syndrome of in- (WN) 35 Technician Certification Policy, American
appropriate secretion of antidiuretic hor- Insomnia, National Sleep Foundation formed Journal ofH ospital Pharmacy (1991) 107;
mone (A) 52 (WN) 208; estazolam Civ marketed (WN) ASHP Technical Assistance Bulletin, Ameri-
Glycerin, as sweetening agent (A) 171 79 can Journal of Hospital Pharmacy (1991) 72;
Goff, Debra A. (coauthor) see Thornton, John Institutional review boards, clinical trials (A) Enhancing the Future of Pharmaceutical
P., 195 10 Education and Practice, Miller, William A.,
Gorman, Sean P. (author) book review, 166 Insulin, methods of delivery (A) 20; pharma- American Journal of Pharmaceutical Education
Guidelines for Compounding Oral Medica- cokinetics ‘ A) 19; pumps (A) 21; therapy (1990) 32; Mammography Saves Lives, FDA
tions for Pediatric Patients (A) 168 (A) 19 Consumer (1991) 204; More Healthcare for
Guidelines for Dilution of Intravenous Interferon gamma-1b, introduced (WN) 37 Less Mi —Editorial and Comment, New
Drugs for Pediatric Patients (A) 132 Iodinated Glycerol Products Added (WN) York Times (1991) 155; Nosocomial Pseu-
Guidelines for the Administration of Intra- 245 domonas picketti Bacteremias Traced to Nar-
venous Potassium Chloride (U) 118 Isoniazid, interaction with alcohol (PF) 238 cotic Tampering, Maki, Dennis G., Journal of
Guidelines for the Pharmacist on the Role of Issues in Contemporary Drug Delivery: Part the American Medical Association (1991) 32;
the Pharmacy Technician (A) 143 IV. Insulin Therapy (A) 19 Only a Tech? Journal Michigan Pharmacist
Guy, Jerry T. (coauthor) see Thornton, John Ives, Timothy J. (author) book review, 216 (1991) 204; Orphan Drug Act, Journal of the
P., 195 Journal appointments, Consulting Editors American Medical Association (1991) 72; Phar-
Gynex Receives Orphan Drug Designation Chosen, 165 macy Certified Technicians—Implications
for AIDS Drug (WN) 245 journal of Pharmacy Technology, author of Validating the PCT Exam, Journal Michi-
Hales, Beverly (coauthor) see Koren, Gideon, guidelines JF-ifc, MA-ifc, MJ-ifc, JA-ifc, SO- gan Pharmacist (1991) 107; Pharmacy Tech-
219 ifc, ND-ifc; growth and future (A) 81; nician Skills in Home Care, Baczewski,
Hart, Linda L. (coauthor) see Wong, Carolyn reprints, columns, opinions, and standards David H., and DeVries, Patricia, Journal
F., 47 MJ-ibc, JA-ibc, major articles JF-ibc, MA-ibc, Michigan Pharmacist (1991) 242; Preventing
Hatoum, Hind T. (author) book review, 217 SO-ibe, ND-ibec Travelers’ Ailments, FDA Consumer (1991)
Hemophilia B, new clotting agent developed jPT: A Bargain for the Whole Department (L) 108; RPh Reinstated After Infant's Death;
(WN) 36 124 Tech Goes, Hospital Pharmacist Report (1991)
Henann, Neil E. (coauthor) see Yamreudee- Kelly, William N. (author) book review, 166 156; Revised FDA Regulations for Sun-
wong, Weeranuj, 50 Keresztes, Jan M., appointed jPT consulting screen Labeling Expected, Journal of the
Heparin, interaction with alcohol (PF) 238 editor (JA) 165 American Medical Association (1991) 206;
Hepatitis C, recombinant interferon alfa ap- Ketoconazole, adverse effects (A) 49; vaginal State Societies Make Headway in Formaliz-
proved (WN) 111 candidiasis (A) 47 ing Technician Role, American Journal of
Hermann, Joachim J. (author) Milliequivalent Ketoconazole in Vaginal Candidiasis (A) 47 Hospital Pharmacy (1991) 240; Technician
Units: Rationale and Applications in Phar- King Khalid University Hospital Drug and Economic Survey, Journal Michigan Pharma-
macy (A) 145 Poison Information Service: A Descriptive cist (1991) 31; Technician Education and
H thylmel , see altretamine Report and Comparison with the Univer- Training: A Message from the President of
Hipple, Thomas F. (coauthor) see Nahata, sity of Minnesota Drug Information Cen- the Arizona Pharmacy Association, Arizona
Milap C., 132, 216 ter (A) 179 Pharmacist (1991) 201; Tobacco Advertising
journal of Pharmacy Technology Volume 7 November/December 1991 255
in Retail Stores, Cummings, K. Michael, New Agent for Schizophrenia (WN) 248 Oxidative stress status, routine screening rec-
Sciandra Russell, Lawrence, James, Public New Antihypertensive Benefits Older Pa- ommended (WN) 209
Health Reports (1991) 242; Tracking the Cost tients (WN) 210 Oxipurinol, role in development of allopuri-
of Healthcare, Advances (1991) 241 New Blood Clotting Agent (WN) 36 nol toxicity (A) 226
Lithium, interaction with alcohol (PF) 238 New Chemotherapeutic Protector (WN) 246 Packaging, change in child-resistant closures
Long-term care facilities, antipsychotic drug New Electronic Scientific Research Tool supported (PF) 239
use (A) 13 (WN) 110 Pain, analgesic use (A) 86
Luks, Denise B. (coauthor) see Sinnett, Mark New Enteral Formula Reduces Hospital Stay Pancytopenia Associated with the Interac-
J., 89 (PF) 29 tion of Allopurinol and Azathioprine (A)
Lyphomed Amphotericin B Approved (WN) New Foundation to Help Americans Sleep 224
36 Better (WN) 208 Parabens, as a preservative (A) 173
Magnesium aluminum silicate, as suspend- New Hypertension Drug Approved (WN) 79 Patent for Photodynamic Therapy of Tumors
ing agent (A) 172 New Medicine Stations from Jewett (WN) 247 Issued (WN) 34
Majka, Stan (author) jPT: A Bargain for the New Mexico, legislation to formally recognize Pediatric patients, captopril (L) 216; com-
Whole Department (L) 124 technicians defeated (FL) 240 pounding oral medications (A) 168
Makooi-Morehead, Mina (author) Estimating New Product Counters Medication Compli- Pentazocine, use for pain management (A) 86
Drug Shelf Life at Various Storage Temper- ance Problems (WN) 248 P 1 , use in pain manage-
atures (A) 176 New Product for Cancer Pain Relief (WN) ment (A):8 7
Mammography Saves Lives (FL) 204 247 Peptic ulceration, associated with NSAID use
Management, financial (NP) 217 New Public Service Newsletter on Rosacea (A) 89
Mania, treatment with valproate (PF) 71 (WN) 244 Personal Notes, Michael Prater Seriously In-
McKibben, Bruce E. (author) Technician in New Test Strips for Easy Screening of Mi- jured; Now Recovering, 45
Stuttgart Requests Information (L) 44 croalbuminuria (WN) 211 Pharmacies, chain, independent, use of auxil-
Measles, Vitamin A (PF) 71 New TPN Compounder from Baxa (WN) 211 iary labels (A) 66
Medication counseling, alcohol (PF) 228 New USP Labeling Requirement for Vin- Pharmacists, impact on antibiotic prescribing
Medicine stations, new models introduced cristine (PF) 104 (A) 195
(WN) 247 Niacin, reduction of recurrent myocardial in- Pharmacists Support Change in Child-Resis-
Meprobamate, interaction with alcohol (PF) farctions (PF) 71 tant Packaging Regulations (PF) 239
y Nickel, Ronald (coauthor) see Dombrowski, Pharmacokinetics (NP) 217
Methylcellulose, as suspending agent (A) 172 Robert C., 64 Pharmacy Certified Technician Examination
Methyinaltrexone, licensing agreement (WN) Nitrates, interaction with alcohol (PF) 238 Validated (WN) 78
209 Noncomptiance: America’s Other Drug War Pharmacy Certified Technicians—Implica-
Methylparaben, as a preservative (A) 173 (PF) 105 tions of Validating the PCT Exam (FL) 107
Metronidazole, interaction with alcohol (PF) Nonsteroidal antiinflammatory drugs, devel- Pharmacy Focus, Advise About Alcohol with
238 opment of ulceration (A) 89; induce syn- Every Prescription, 238; AIDS Not Caused
Michael Prater Seriously Injured; Now Re- drome of inappropriate secretion of antidi- by Virus?, 29; Anticonvulsant May Be Ac-
covering (PN) 45 uretic hormone (A) 53; interaction with tive in Mania, 71; APhA Seeks Input on
Microalbuminuria, immunoassay available alcohol (PF) 238; use in pain management Code of Ethics, 154; Arizona Pharmacy As-
on test strip (WN) 211 (A) 87 sociation Examination, 201; California Ap-
Milliequivalent Units: Rationale and Appli- Nonwipe Meter for Diabetic Patients (WN) proves New Technician Law, 201; Califor-
cations in Pharmacy (A) 145 112 nia Technician Legislation on the Move,
Monitor for Chemical Changes in Brain (PF) Nortriptyline, induces syndrome of inappro- 104; CPhA Policies Adopted, 29; Du Pont
29 priate secretion of antidiuretic hormone (A) Merck Begins Alzheimer Drug Trials, 201;
Monoamine oxidase inhibitors, interaction 53 FDA Watching Prescription Drug Promo-
with alcohol (PF) 238 Nosocomial Pneumonia in Intensive Care tion, 239; Monitor for Chemical Changes in
Montana, technicians formally recognized Patients Secondary to Stress Ulcer Prophy- Brain, 29; NABP Delegates Recommend
(FL) 240 laxis (A) 127 Resolutions to Executive Committee, 154;
More Healthcare for Less Money—Editorial Nosocomial Pseudomonas picketti Bac- New Enteral Formula Reduces Hospital
and Comment (FL) 155 teremias Traced to Narcotic Tampering Stay, 9; New USP Labeling Requirement for
Morphine, induces syndrome of inappropri- (FL) 32 Vincristine, 104; Noncompliance: America’s
ate secretion of antidiuretic hormone (A) Nutraceutical Initiative Proposed (PF) 71 Other Drug War, 105; Nutraceutical Initia-
53; Oramorph SR introduced (WN) 247; use Nutraceuticals, research encouraged (PF) 71 tive Proposed, 71; Pharmacists Support
in pain management (A) 87 Nutrition, information on fruit and vegetable Change in Child-Resistant Packaging Regu-
Myocardial infarction, niacin (PF) 71 juice to be provided by FDA (WN) 244 lations, 239; Quality Assurance Procedures
Myotrophin, receives orphan drug status Nutrition Regulations Published (WN) 245 for Sterile Product Preparation, 202; “Rare”
(WN) 248 Obstructive sleep apnea, protriptyline (A) 222 Types of Pneumonia May Actually Be
Ofloxacin, treatment of infections (WN) 110 Commonplace, 201
Ondansetron, introduced (WN) 78 Pharmacy Technician Competency Part I. A
Only A Tech? (FL) 203 Comparative Evaluation of Formally
N-P Ontario College of Pharmacists (A) 143 Trained and On-the-Job Trained Pharma-
Oral Floxin for Broad Use Against Common cy Technicians in Minnesota (A) 100; Part
Infections (WN) 110 II: Study Design, Hypotheses, and Results
NABP Delegates Recommend Resolutions to Oramorph SR, introduced (WN) 247 (A) 184; Part III: Statistical Analysis of
Executive Committee (PF) 154 Ora-Plus, as suspending agent (A) 172 Study Results (A) 227
Nahata, Milap C. (author) Captopril for Pedi- Orphan Drug Act (FL) 72 Pharmacy Technician Educators’ Conference
atric Patients (L) 216; Guidelines for Dilu- Orphan Drug Designation for Myotrophin (WN) 34
tion of Intravenous Drugs for Pediatric Pa- (WN) 248 Pharmacy Technician Skills in Home Care
tients (A) 132; (coauthor) see Dawson, Orphan drugs, myotrophin (WN) 248; orphan (FL) 242
Linda M., 168 drug act (FL) 72; oxandrolone (WN) 245 PharmD Deja Vu! Enter the Technician (E)
National Sleep Foundation, formed (WN) Osteoporosis, calcium (PF) 71 161
208 OTC Drug Market Flourishing (WN) 158 Phenelzine, induces syndrome of inappropri-
Neuroleptic drugs, use in long-term care facil- Ovarian Cancer Drug Approved (WN) 37 ate secretion of antidiuretic hormone (A) 53
ities (A) 13 Oxandrolone, receives orphan drug status Phenothiazines, interaction with alcohol (PF)
Nevada, legislation to formally recognize (WN) 245 238
technicians defeated (FL) 240 Oxidant Stress Testing a Possible Key to Phenytoin, hypersensitivity aw (A) 6;
New Abbott Hypnotic (WN) 79 Chronic Disease Prevention (WN) 209 interaction with alcohol (PF)
256 journal of Pharmacy Technology Volume 7 November/December 1991
Phenytoin Hypersensitivity Syndrome: Case lege Education Recommended, Stewart R., Study of Antipsychotic Drug Use in Long-
Report and Discussion (A) 6 Lantos R.L., Hospital Management (1970) 37; Term Care Facilities (A) 13
Photodynamic therapy, patent granted (WN) Technician Dispensing Proficiency, Libby Sucralfate in Prevention of NSAID-Induced
34 G.N., Kirk K.W., Weinswig M.H., Contem- Gastric Mucosal Damage (A) 89
Pneumonia, rare forms may be commonplace porary Pharmacy Practice (1978) 119; Techni- Sucrose, as sweetening agent (A) 171
(PF) 201 cian Issue to Consumers, ASHP Newsletter Sulfonylurea hypoglycemics, interaction
Poison information center, at King Khalid (1979) 112; Technician Job Satisfaction, with alcohol (PF) 238
University Hospital (A) 180 Noel M.W., Hammel RJ., Bootman L,J., Sumner, Edward D. (coauthor) see Hulisz,
Polymyositis, association with collagen (WN) American Journal of Hospital Pharmacy (1982) Darrell T., 13
243 142; Technician Productivity, Bowles G.C., Sunscreens, new FDA labeling requirements
Ponte, Charles D. (author) Rational Analgesic American Journal of Hospital Pharmacy (1958) (FL) 205
Use for Acute and Chronic Pain (A) 86 175; Technicians Better Than Pharmacists, Surgery, satellite pharmacy (PF) 72
Pornograpy, Christians seek to ban sale in Brown R.E., American Journal of Hospital Suspending agents (A) 172
pharmacies (WN) 35 Pharmacy (1961) 30; Technicians in the Fu- Swartz, Karen M. (coauthor) see Timm,
Potassium chloride, administration guide- ture, Millis J.S., Health Administration David M., 179
lines (U) 118 Press (1975) 55; Technicians to Count and Sweetening agents (A) 171
Prescribing, impact of a clinical pharmacist on Pour, Tousignaut D.R., Hospitals (1970) 99 Syndrome of inappropriate secretion of an-
antibiotic prescribing (A) 195 Rangaraj, Uma (coauthor) see Yamreudee- tidiuretic hormone, treatment (A) 53
Preservatives, in medications for pediatric pa- wong, Weeranuj, 50 Syrups, as vehicles, 171; as vehicles (A) 170
tients (A) 173 “Rare” Types of Pneumonia May Actually
Preventing Travelers’ Ailments (FL) 107 Be Commonplace (PF) 201
Product development, microbiological prob- Rational Analgesic Use for Acute and Chron-
lems (NP) 166; overview (NP) 124 ic Pain (A) 86
Propoxyphene, use for acute and chronic pain Recombinant Interferon Alfa for Hepatitis T-V
(A) 86 (WN) 111
Propylene glycol, as a preservative (A) 173 Reich, Anne (coauthor) see Koren, Gideon, Technetium Agent Approved by FDA (WN)
Propylparaben, as a preservative (A) 173 219 79
Prostaglandins, cytoprotective qualities (A) 90 Repipet Dilutors from Labindustries (WN)
Technician Economic Survey (FL) 31
Protriptyline for Treatment of Obstructive 210 Technician Education and Training: A Mes-
Sleep Apnea (A) 222 Research, electronic tools (WN) 110 sage from the President of the Arizona
Publications, New, American Jurisprudence: Revised FDA Regulations for Sunscreen La- Pharmacy Association (FL) 203
Proof of Facts—Injuries from Drugs (J. O’Don- beling Expected (FL) 205 Technician Education and Training Pro-
nell) 4; Biopharmaceutics and Clinical Pharma- Riedlinger, June (author) book review, 44 grams: 1991 Update (A) 135
cokinetics, 4th Edition (M. Gibaldi) 217; Co- Rosacea, newsletter published (WN) 244 Technician in Stuttgart Requests Informa-
caine: Facts and Dangers (L. Braunstein) 44; RPh Reinstated After Infant’s Death; Tech tion (L) 44
Financial Management for Pharmacists: A De- Goes (FL) 156 Technicians, attitudes (FL) 203; certification
cision-Making Approach (N.V. Carroll) 217; Saccharin, as sweetening agent (A) 172 policy approved by ASHP (FL) 106; compe-
Guide to Microbiological Control in Pharma- Salicylates, interaction with alcohol (PF) 238 tency (A) 100, 184, 227; enlarging technician
ceuticals (S.P. Denyer and R.M. Baird) 166; Sargramostim, received marketing clearance roles (A) 93; home healthcare (FL) 242; im-
Inside the Drug Industry (B. Spilker) 124; (WN) 111 proving job satisfaction (A) 93; pharmacy
Pharmaceutical Calculations (M.J. Stoklosa, Satellite pharmacy, in surgery and anesthesi- certified technician program (FL) 107; state
H.C. Ansel) 124; Preventing and Controlling ology areas (PF) 72 hospital pharmacy societies (FL) 240; train-
Drug Abuse (World Health Organization) Schizophrenia, sertindole to be tested (WN) ing, on-the-job vs. formal (A) 100,184, 227,
216; 200 Medication Errors and How to Avoid 248 responsibility for (A) 98; use authorized in
Them (M.R. Cohen) 165; Wound Management Schuna, Arthur A. (coauthor) see Dombrows- all practice settings in California (PF) 201;
and Dressings (S. Thomas) 125 ki, Robert C., 64 use in outpatient setting (PF) 104
Pump, insulin (A) 23; miniature infusion Scientists Isolate Gene for Enzyme Implicat- Temperature, effect on drug stability (A) 174,
(WN) 35 ed in Mental Disorders (WN) 158 176
Pyridoxine, treatment and prevention of de-
Segal, Richard (coauthor) see Thornton, John Test Your Knowledge, answers, 38, 77, 117,
pression (PF) 71 P., 195 157, 207, 249; questions, 5, 46, 85, 126, 167,
Sertindole, use in schizophrenia (WN) 248 237
Shaughnessy, Allen F. (coauthor) see Dom- Theophylline, interpatient variability (A) 59;
browski, Robert C., 64 long-term variability (A) 59; serum concen-
Q-S SIADH, see syndrome of inappropriate se- trations in asthmatic children (A) 59
cretion of antidiuretic hormone Thiazides, induce syndrome of inappropriate
Sinnett, Mark J. (author) Sucralfate in Preven- secretion of antidiuretic hormone (A) 52
Quality Assurance Procedures for Sterile tion of NSAID-Induced Gastric Mucosal Thiothixene, induces syndrome of inappro-
Product Preparation (PF) 202 Damage (A) 89 priate secretion of antidiuretic hormone (A)
Quotes, Historical, Community Pharmacy Sleep disorders, National Sleep Foundation 53
Technicians, Tindall W.N., McEvilla J.D., formed (WN) 208; obstructive sleep apnea Thornton, John P. (author) Impact of a Clini-
Journal of the American Pharmaceutical Associ- (A) 222 cal Pharmacist on Antibiotic Prescribing (A)
ation (1972) 153; Future for Technicians, Sodium metabisulfite, as a preservative (A) 173 195
Archambault G.F., Pharmacy-medicine- Solutions, total parenteral nutrition, com- Thuo, H. Michael (author) Pharmacy Techni-
nursing conference on health education pounder developed (WN) 211 cian Competency, Part I. A Comparative
proceedings (1967) 103; Pharmacy Lags in Sorbitol, as sweetening agent (A) 171 Evaluation of Formally Trained and On-
Delegation, Barker K.N., Smith M.C., Amer- South Carolina, use of auxiliary labels by the-Job Trained Pharmacy Technicians in
ican Journal of Hospital Pharmacy (1972) 70; pharmacists (A) 64 Minnesota (A) 100; Part II: Study Design,
Responsibilities of Technicians, Archam- Spooner, Susan H. (author) Improving Job Hypotheses, and Results (A) 184; Part III:
bault G.F., American Journal of Hospital Phar- Satisfaction and Enlarging the Role of Tech- Statistical Analysis of Study Results (A) 227
macy (1958) 58, Trygstad V.O., Hospitals, nicians (A) 93 Tice Substrain Approved (WN) 78
Journal of the American Hospital Association State Societies Make Headway in Formaliz- Timm, David M. (author) King Khalid Uni-
(1963) 8; Students as Apprentices, Pike M., ing Technician Role (FL) 240 versity Hospital Drug and Poison Informa-
Bulletin of the American Society of Hospital Sterile product preparation, formal training tion Service: A Descriptive Report and
Pharmacists (1957) 221; Technician Certifi- recommended (PF) 202; technique (U) 252 Comparison with the University of Min-
cation and Recognition, Whitney Jr., Sterile Technique and Intravenous Drug nesota Drug Information Center (A) 179
H.A.K., The Apothecary, 92; Technician Col- Preparation (U) 252 Tobacco, advertising in retail stores (FL) 242;
journal of Pharmacy Technology Volume 7 November/December 1991 257
Christians seek to ban sale in pharmacies Approve Recommendation, 35; Cold- Educators’ Conference, 34; Recombinant In-
(WN) 35; health industries and investment Adapted Influenza Virus Vaccine, 110; terferon Alfa for Hepatitis, 111; Repipet Di-
portfolios (WN) 109 Combination HIV Antibody Test Kits, 246; lutors from Labindustries, 210; Scientists
Tobacco Advertising in Retail Stores (FL) 242 Computerized Medication Dispenser, 111; Isolate Gene for Enzyme Implicated in
Tolbutamide, induces syndrome of inappro- CytoGuard Safety Device, 79; DDC Re- Mental Disorders, 158; Technetium Agent
priate secretion of antidiuretic hormone (A) ceives Treatment IND Status, 210; Diabetes Approved by FDA, 79; Tice Substrain Ap-
52 Overlooked in Favor of Other Life-Threat- proved, 78; Value of Pharmacy Services to
Tracking the Cost of Healthcare (FL) 241 ening Diseases, 208; Disposable, Hand- be Studied, 158; Versa-lok IV Connector,
Tranylcypromine, induces syndrome of inap- Held Cholesterol Test, 247; Divestment 159; Zofran for Chemotherapy-Induced
propriate secretion of antidiuretic hormone from Tobacco Stocks Urged, 109; Drug Emesis, 78
(A) 53 Testing for Turner Syndrome, 159; Elan Ac- Whitney, Harvey A.K. Jr. (author) Dispensing
Tumors, ovarian, altretamine (WN) 37; photo- quires Rights to Miniature Infusion Pump, and the Technician: Part I (E) 1, Part I (E)
dynamic therapy, patent granted (WN) 34 35; Epoetin Alfa for Anemia, 36; Exclusive 41; Errors as a Way of Life. Part V. Who Is
Updating Your Skills, Guidelines for the Ad- License Granted for Diaziquone, 112; FDA Responsible? (E) 213; For jPT—A Problem
ministration of Intravenous Potassium Acts on Benzoyl Peroxide, 244; FDA Reor- Becomes an Opportunity (E) 121; PharmD
Chloride, 118; Sterile Technique and Intra- ganization, 208; FDA Reviews New Zi- Deja Vu! Enter the Technician (E) 161; The
venous Drug Preparation, 252 dovudine Data, 78; Fisons Corporation Growth of jPT and Its Future (E) 81
Use of Clinical Pharmacists to Prevent Medi- Sues Professional Compounding Centers of Williams, Patricia A. (coauthor) see Spooner,
cation Errors in Children (A) 219 America, 35; Free Home Blood Pressure Susan H., 93
Vaccines, influenza (WN) 110 Monitors, 109; Genentech Granted Product Wong, Carolyn F. (author) Ketoconazole in
Valproate, use in mania (PF) 71 License for Actimmune, 37; Gynex Receives Vaginal Candidiasis (A) 47
Value of Pharmacy Services to be Studied Orphan Drug Designation for AIDS Drug, Wound management, overview (NP)
(WN) 158 245; Hopkins Makes Brain Cell Culture Xanthan gum, as suspending agent (A) 172
Variability of Serum Theophylline Concen- Available for Licensing, 109; Immunex to Xylitol, as sweetening agent (A) 172
trations in Outpatient Asthmatic Children Market Leukine, 111; lodinated Glycerol Yamreudeewong, Weeranuj (author) Drug-
(A) 59 Products Added, 245; Licensing Agreement Induced Syndrome of Inappropriate Secre-
Veegum, see magnesium aluminum silicate for Methylnaltrexone, 209; Lyphomed Am- tion of Antidiuretic Hormone (A) 50
Versa-lok [TV Connector (WN) 159 photericin B Approved, 36; New Abbott Zidovudine, FDA reviews new data (WN) 78;
Verschoor, Barbara A. (coauthor) see Spoon- Hypnotic, 79; New Agent for Schizophre- adverse effects (WN) 210
er, Susan H., 93 nia, 248; New Antihypertensive Benefits Zofran For Chemotherapy-Induced Emesis
Vidarabine, induces syndrome of inappropri- Older Patients, 210; New Blood Clotting (WN) 78
ate secretion of antidiuretic hormone (A) 53 Agent, 36; New Chemotherapeutic Protec-
Vincristine, induces syndrome of inappropri- tor, 246; New Electronic Scientific Research
ate secretion of antidiuretic hormone (A) 52 Tool, 110; New Foundation to Help Ameri-
Vincristine sulfate, new labeling requirement cans Sleep Better, 208; New Hypertension
(PF) 104 Drug Approved, 79; New Medicine Sta- ADVERTISERS
Vitamin A, treatment and prevention of tions from Jewett, 247; New Product Coun-
measles (PF) 71 ters Medication Compliance Problems, 248; Association of Pharmacy Technicians, annual
New Product for Cancer Pain Relief, 247; convention, 84
New Public Service Newsletter on Rosacea, Glaxo Pharmaceuticals, Ceptaz, 74, 114
244; New Test Strips for Easy Screening of Harvey Whitney Books, A Casebook in Social
w-z Microalbuminuria, 211; New TPN Com- and Behavioral Pharmacy, 116, 194; Books,
pounder from Baxa, 211; Nonwipe Meter Journals, and Reprints for Pharmacy and
for Diabetic Patients, 112; Nutrition Regula- Pharmacotherapy, 234; Pharmacoepidemi-
Weart, C. Wayne (coauthor) see Hulisz, Dar- tions Published, 245; Oral Floxin Broad Use ology, An Introduction, Second Edition, 39;
rell T., 13 Against Common Infections, 110; Orphan Pharmacy and Pharmacotherapy Publica-
Wertheimer, Albert I. (coauthor) see Thuo, H. Drug Designation for Myotrophin, 248; tions, 113; Principles of Pharmacoeco-
Michael, 100, 184, 227 OTC Drug Market Flourishing, 158; Ovari- nomics, 76; SIMKIN Handbook of Thera-
What's New, AccuTRAK for Improved Com- an Cancer Drug Approved, 37; Oxidant peutic Monitoring, 39; The Practice of
pliance, 36; Association Between Connec- Stress Testing a Possible Key to Chronic Pharmacy, 206
tive Tissue Diseases and Collagen, 243; Disease Prevention, 209; Patent for Photo- PharmaCE, 212, 251
Canadians Pay Less for Drugs Than Do dynamic Therapy of Tumors Issued, 34; Pharmacists for Life 82
Americans, 34; Centoxin Approved in Ger- Pharmacy Certified Technician Examina- Pharmacy International Christians Associa-
many and UK, 159; Christian Pharmacists tion Validated, 78; Pharmacy Technician tion, annual meeting, 88
Volume 7 November/December 1991